Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9NP90

Entry ID Method Resolution Chain Position Source
2OCB X-ray 220 A A 2-180 PDB
AF-Q9NP90-F1 Predicted AlphaFoldDB

69 variants for Q9NP90

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1484145278
CA414105944
10 V>A No ClinGen
gnomAD
CA414105953
rs1569435472
10 V>F No ClinGen
Ensembl
TCGA novel 19 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 25 N>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772724187
CA10479112
27 Y>F No ClinGen
ExAC
gnomAD
rs1321964920
CA414105704
COSM456391
28 V>I Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
TCGA novel 29 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1423771837
CA414105657
31 K>N No ClinGen
TOPMed
CA414105588
rs1309418405
36 A>G No ClinGen
gnomAD
rs1426691402
CA414105541
40 I>V No ClinGen
gnomAD
rs1375904490
CA414105443
47 R>* No ClinGen
TOPMed
gnomAD
CA414105445
rs1375904490
47 R>G No ClinGen
TOPMed
gnomAD
rs372399381
CA10479109
47 R>Q No ClinGen
ESP
ExAC
gnomAD
rs1483264654
CA414105436
48 D>N No ClinGen
gnomAD
rs770371462
CA10479108
49 L>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 53 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10479107
rs746386881
54 R>C No ClinGen
ExAC
TOPMed
gnomAD
CA10479106
rs777348859
54 R>H No ClinGen
ExAC
rs1436117708
CA414105332
56 V>L No ClinGen
gnomAD
rs771123821
CA10479105
58 L>V No ClinGen
ExAC
gnomAD
rs968207592
CA334004298
62 D>G No ClinGen
Ensembl
CA414105197
rs1344910465
66 Q>* No ClinGen
gnomAD
rs1221850245
CA414104755
84 L>F No ClinGen
TOPMed
CA10479101
rs747849601
86 T>I No ClinGen
ExAC
gnomAD
CA10479099
rs181295698
89 V>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1202532042
CA414104645
92 R>Q No ClinGen
TOPMed
CA414104646
rs1334219094
92 R>W No ClinGen
gnomAD
CA10479097
rs188884979
96 E>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA414104499
rs1472769494
99 G>D No ClinGen
gnomAD
rs990471942
CA334004297
104 E>K No ClinGen
TOPMed
rs1263222153
CA414104405
106 I>V No ClinGen
TOPMed
rs1411004945
CA414104344
109 A>V No ClinGen
TOPMed
gnomAD
CA414104289
rs1367306590
112 K>R No ClinGen
gnomAD
CA10479092
rs372221720
114 P>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1441919665
CA414104217
116 H>R No ClinGen
gnomAD
rs765696707
CA10479091
116 H>Y No ClinGen
ExAC
CA10479090
rs760039495
118 P>H No ClinGen
ExAC
gnomAD
rs182265761
CA334004295
121 V>L No ClinGen
1000Genomes
CA10479088
rs771608148
123 G>V No ClinGen
ExAC
gnomAD
CA10479086
rs773366134
131 R>K No ClinGen
ExAC
gnomAD
CA414103950
rs1358421272
134 T>A No ClinGen
TOPMed
CA10479085
rs199858408
134 T>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 135 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10479084
rs748406972
136 E>Q No ClinGen
ExAC
gnomAD
rs1338218102
CA414103918
136 E>V No ClinGen
gnomAD
CA10479083
rs779172372
137 E>K No ClinGen
ExAC
gnomAD
rs754752803
CA10479082
140 T>A No ClinGen
ExAC
CA334004294
rs1034798711
143 M>T No ClinGen
TOPMed
TCGA novel 146 G>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA414103720
rs1403175151
147 D>G No ClinGen
TOPMed
TCGA novel 148 Y>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749128249
CA10479081
148 Y>F No ClinGen
ExAC
gnomAD
TCGA novel 149 P>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA10479080
rs779932850
152 E>A No ClinGen
ExAC
gnomAD
CA334004293
rs926216691
155 A>S No ClinGen
Ensembl
TCGA novel 157 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA334004292
rs978913807
158 D>Y No ClinGen
Ensembl
rs1416148426
CA414103527
159 T>A No ClinGen
gnomAD
CA414103501
rs1182675040
163 V>M No ClinGen
gnomAD
rs767064049
CA10479077
168 A>T No ClinGen
ExAC
gnomAD
CA10479076
rs756788594
169 V>I No ClinGen
ExAC
gnomAD
CA414103440
rs1278111672
172 V>M No ClinGen
TOPMed
COSM3424310
CA10479072
rs754287809
176 E>D Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs761814878
CA10479070
181 H>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs368010774
CA10479069
191 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA10479068
rs772188064
195 K>E No ClinGen
ExAC
gnomAD
rs1602401762
CA414103120
197 G>W No ClinGen
Ensembl
CA10479067
rs761856500
199 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs1266097474
CA414103051
202 C>E No ClinGen
TOPMed

No associated diseases with Q9NP90

1 regional properties for Q9NP90

Type Name Position InterPro Accession
domain Small GTP-binding protein domain 9 - 166 IPR005225

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane ; Lipid-anchor ; Cytoplasmic side
  • Cytoplasmic vesicle, phagosome
  • Cytoplasmic vesicle, phagosome membrane ; Lipid-anchor ; Cytoplasmic side
  • Recruited to phagosomes containing S
  • aureus or M
  • tuberculosis
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
late endosome A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
lysosome A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
phagocytic vesicle A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis.
phagocytic vesicle membrane The lipid bilayer surrounding a phagocytic vesicle.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
secretory granule membrane The lipid bilayer surrounding a secretory granule.

4 GO annotations of molecular function

Name Definition
GDP binding Binding to GDP, guanosine 5'-diphosphate.
GTP binding Binding to GTP, guanosine triphosphate.
GTPase activity Catalysis of the reaction: GTP + H2O = GDP + H+ + phosphate.
identical protein binding Binding to an identical protein or proteins.

3 GO annotations of biological process

Name Definition
protein transport The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
Rab protein signal transduction The series of molecular signals within the cell that are mediated by a member of the Rab family of proteins switching to a GTP-bound active state.
retrograde transport, endosome to Golgi The directed movement of membrane-bounded vesicles from endosomes back to the trans-Golgi network where they are recycled for further rounds of transport.

7 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P51149 RAB7A Ras-related protein Rab-7a Homo sapiens (Human) PR
P51150 Rab7a Ras-related protein Rab-7a Mus musculus (Mouse) PR
Q9R0M6 Rab9a Ras-related protein Rab-9A Mus musculus (Mouse) PR
P09527 Rab7a Ras-related protein Rab-7a Rattus norvegicus (Rat) PR
Q99P75 Rab9a Ras-related protein Rab-9A Rattus norvegicus (Rat) PR
Q9C820 RABG3D Ras-related protein RABG3d Arabidopsis thaliana (Mouse-ear cress) PR
Q9LW76 RABG3C Ras-related protein RABG3c Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MSGKSLLLKV ILLGDGGVGK SSLMNRYVTN KFDSQAFHTI GVEFLNRDLE VDGRFVTLQI
70 80 90 100 110 120
WDTAGQERFK SLRTPFYRGA DCCLLTFSVD DRQSFENLGN WQKEFIYYAD VKDPEHFPFV
130 140 150 160 170 180
VLGNKVDKED RQVTTEEAQT WCMENGDYPY LETSAKDDTN VTVAFEEAVR QVLAVEEQLE
190 200
HCMLGHTIDL NSGSKAGSSC C